ZVRA
Zevra Therapeutics Inc
NASDAQ · Pharmaceuticals
$8.60
+0.24 (+2.87%)
Open$8.53
Previous Close$8.36
Day High$8.75
Day Low$8.48
52W High$13.16
52W Low$6.19
Volume—
Avg Volume876.3K
Market Cap500.06M
P/E Ratio14.16
EPS$0.59
SectorPharmaceuticals
Analyst Ratings
Strong Buy
14 analysts
Price Target
-37.9% upside
Current
$8.60
$8.60
Target
$5.34
$5.34
$3.67
$5.34 avg
$6.76
Key Financials
| FY 2026 | FY 2025 | FY 2025 | |
|---|---|---|---|
| Revenue | 29.68M | 31.66M | 114.07M |
| Net Income | -132,649,822 | -127,330,247 | 32.69M |
| Profit Margin | -446.9% | -424.5% | 28.7% |
| EBITDA | -98,761,988 | -100,068,140 | 65.90M |
| Free Cash Flow | — | — | 17.86M |
| Rev Growth | -6.2% | -6.2% | +11.2% |
| Debt/Equity | 1.50 | 1.50 | 0.39 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,058.18 | +3.66% | 48.5 | 1.00T |
| JNJ | Johnson & Johnson | $239.99 | +0.93% | 21.6 | 578.21B |
| MRK | Merck & Co. Inc. | $121.93 | +1.82% | 16.6 | 302.63B |
| PFE | Pfizer Inc. | $27.22 | +2.76% | 19.9 | 154.76B |
| BMY | Bristol-Myers Squibb Co | $61.99 | +4.15% | 17.9 | 126.20B |
| ZTS | Zoetis Inc | $127.42 | +0.54% | 21.5 | 56.95B |